Tempest Therapeutics, Inc.
CUSIP 87978U108
Tempest Therapeutics, Inc. has 1 institutional holders in Filings Flow’s 13F database, together reporting 269.8K shares worth $442,426 as of Q1 2026.
Institutional Holders
1
Q1 2026
Reported Value
$442,426
Ticker
unmapped
private placement or foreign
Quarters Tracked
20
Ownership Trend
Institutional holders
Total reported value
Holders
··
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| Versant Venture Management, LLC$141M AUM | 0.31% | $442,426 | 269.8K | Q1 2026 |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.